Chemotherapy

What is it?
  • The use of specific drugs to treat cancer.
  • Normally used to treat recurring or metastatic prostate cancer if hormone therapy does not work anymore.
  • Chemotherapy drugs affect both cancer cells and healthy cells. Healthy cells tend to regenerate whereas cancer cells struggle to do so.
  • It is sometimes used to treat more advanced cancer in conjunction with surgical removal of the prostate.
For more information about chemotherapy drugs visit our Prostate Cancer Drugs page.

What is done?

Chemotherapy is usually given through the vein but some forms can be taken as a pill.

 
What to expect?

Chemotherapy is typically used to slow the prostate cancer’s spread, prolong life, and relieve pain associated with the late stages of cancer.


Side effects and risks

Specific side-effects depend on the type of drugs that are given. The following side-effects are common with most types of chemotherapy:
  • Gastrointestinal side-effects such as nausea, vomiting and diarrhea
  • Anemia
  • Total or partial hair loss
  • Sensitive skin
  • Infertility
  • Vulnerability to infection (most commonly chest, mouth, throat and urinary infections)
  • Nail changes
Some side-effects can be treated with other drugs; others continue until chemotherapy is stopped.


 

For more information and support:


Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More


Click here for news archive